Fabı́ola Traina

4.3k total citations
160 papers, 2.6k citations indexed

About

Fabı́ola Traina is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Fabı́ola Traina has authored 160 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 113 papers in Hematology, 71 papers in Genetics and 60 papers in Molecular Biology. Recurrent topics in Fabı́ola Traina's work include Acute Myeloid Leukemia Research (76 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (33 papers) and Hemoglobinopathies and Related Disorders (26 papers). Fabı́ola Traina is often cited by papers focused on Acute Myeloid Leukemia Research (76 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (33 papers) and Hemoglobinopathies and Related Disorders (26 papers). Fabı́ola Traina collaborates with scholars based in Brazil, United States and United Kingdom. Fabı́ola Traina's co-authors include Sara Teresinha Olalla Saad, João Agostinho Machado‐Neto, Fernando Ferreira Costa, Patrícia Favaro, Ramón V. Tiu, Valeria Visconte, Nicola Conran, Mikkael A. Sekeres, Paula de Melo Campos and Hideki Makishima and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Fabı́ola Traina

146 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fabı́ola Traina Brazil	28	1.3k	1.2k	909	369	282	160	2.6k
Keita Kirito Japan	29	1.1k 0.8×	1.2k 1.0×	585 0.6×	375 1.0×	433 1.5×	128	2.3k
Véronique Mansat‐De Mas France	25	1.4k 1.1×	1.3k 1.0×	546 0.6×	358 1.0×	428 1.5×	57	2.5k
Michèle Souyri France	22	1.2k 1.0×	909 0.8×	547 0.6×	475 1.3×	332 1.2×	47	2.5k
Matthew R. Warr United States	17	876 0.7×	1.6k 1.4×	454 0.5×	477 1.3×	383 1.4×	30	2.9k
Hélène Lapillonne France	22	905 0.7×	1.5k 1.2×	495 0.5×	331 0.9×	285 1.0×	57	2.7k
Frédéric Larbret France	20	746 0.6×	1.1k 0.9×	569 0.6×	218 0.6×	357 1.3×	32	2.0k
Goro Sashida Japan	28	1.1k 0.9×	2.0k 1.6×	404 0.4×	287 0.8×	390 1.4×	88	2.7k
Matthias Mayerhofer Austria	32	1.1k 0.9×	1.3k 1.1×	820 0.9×	1.3k 3.5×	446 1.6×	75	3.2k
Marco Gabbianelli Italy	27	1.3k 1.0×	1.4k 1.2×	821 0.9×	520 1.4×	374 1.3×	68	2.7k
Yuichi Ishikawa Japan	23	667 0.5×	1.4k 1.1×	342 0.4×	168 0.5×	476 1.7×	113	2.5k

Countries citing papers authored by Fabı́ola Traina

Since Specialization

Citations

This map shows the geographic impact of Fabı́ola Traina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabı́ola Traina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabı́ola Traina more than expected).

Fields of papers citing papers by Fabı́ola Traina

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fabı́ola Traina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabı́ola Traina. The network helps show where Fabı́ola Traina may publish in the future.

Co-authorship network of co-authors of Fabı́ola Traina

This figure shows the co-authorship network connecting the top 25 collaborators of Fabı́ola Traina. A scholar is included among the top collaborators of Fabı́ola Traina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fabı́ola Traina. Fabı́ola Traina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pereira‐Martins, Diego A., et al.. (2025). A common ground: an in silico assessment of the sources of intrinsic ex vivo resistance to venetoclax in acute myeloid leukemia. Hematology Transfusion and Cell Therapy. 47(2). 103758–103758. 1 indexed citations

Pereira‐Martins, Diego A., et al.. (2024). Autophagy and inflammasome activation are associated with poor response to FLT3 inhibitors in patients with FLT3-ITD acute myeloid leukemia. Scientific Reports. 14(1). 23882–23882. 2 indexed citations

Neto, Miguel Moysés, et al.. (2023). Isolated massive histiocytes renal interstitial infiltration: a case report of an unexpected cause of acute kidney injury in a kidney transplant recipient. BMC Nephrology. 24(1). 77–77.

Biasoli, Irène, Nelson Castro, Fabı́ola Traina, et al.. (2023). Treatment outcomes in classic Hodgkin lymphoma: 5‐year update from the Brazilian Hodgkin Lymphoma Registry. SHILAP Revista de lepidopterología. 4(4). 1191–1195.

Velloso, Elvira Deolinda Rodrigues Pereira, Alex Freire Sandes, Fabı́ola Traina, et al.. (2022). Diagnosis and treatment of systemic mastocytosis in Brazil: Recommendations of a multidisciplinary expert panel. Hematology Transfusion and Cell Therapy. 44(4). 582–594.

Pereira‐Martins, Diego A., Isabel Weinhäuser, Juan Luiz Coelho‐Silva, et al.. (2021). MLL5 improves ATRA driven differentiation and promotes xenotransplant engraftment in acute promyelocytic leukemia model. Cell Death and Disease. 12(4). 371–371. 6 indexed citations

Coelho‐Silva, Juan Luiz, Renata Scopim‐Ribeiro, Priscila Santos Scheucher, et al.. (2020). NT157 has antineoplastic effects and inhibits IRS1/2 and STAT3/5 in JAK2V617F-positive myeloproliferative neoplasm cells. Signal Transduction and Targeted Therapy. 5(1). 5–5. 24 indexed citations

Quek, Lynn, Itamar S Santos, Juan Luiz Coelho‐Silva, et al.. (2020). Integrating clinical features with genetic factors enhances survival prediction for adults with acute myeloid leukemia. Blood Advances. 4(10). 2339–2350. 10 indexed citations

Coelho‐Silva, Juan Luiz, Grant Vallance, Diego A. Pereira‐Martins, et al.. (2020). A multicenter comparative acute myeloid leukemia study: can we explain the differences in the outcomes in resource-constrained settings?. Leukemia & lymphoma. 62(1). 147–157. 6 indexed citations

10.

Santos, Fábio Pires de Souza, et al.. (2019). Reversine exhibits antineoplastic activity in JAK2V617F-positive myeloproliferative neoplasms. Scientific Reports. 9(1). 9895–9895. 13 indexed citations

11.

Machado‐Neto, João Agostinho, et al.. (2018). Effects of RhoA and RhoC upon the sensitivity of prostate cancer cells to glutamine deprivation. Small GTPases. 12(1). 20–26. 7 indexed citations

12.

Machado‐Neto, João Agostinho, Paula de Melo Campos, Juan Luiz Coelho‐Silva, et al.. (2017). The pharmacological IGF1R-IRS1/2 inhibitor NT157 presents multiple anti-neoplastic effects in myeloproliferative neoplasms. Blood. 130. 1253. 2 indexed citations

13.

Coelho‐Silva, Juan Luiz, et al.. (2017). IGF signaling predicts outcomes and is a promising target therapy for acute myeloid leukemia. Blood. 130. 3966–3966.

14.

Machado‐Neto, João Agostinho, et al.. (2016). IRS1/β‐Catenin Axis Is Activated and Induces MYC Expression in Acute Lymphoblastic Leukemia Cells. Journal of Cellular Biochemistry. 118(7). 1774–1781. 16 indexed citations

15.

Machado‐Neto, João Agostinho, et al.. (2016). Reversine triggers mitotic catastrophe and apoptosis in BCR-ABL positive cells. Haematologica. 101. 733. 1 indexed citations

16.

Visentainer, Jeane Eliete Laguila, Paula de Melo Campos, Fabı́ola Traina, et al.. (2015). Molecular matching for Rh and K reduces red blood cell alloimmunisation in patients with myelodysplastic syndrome.. LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas). 13(1). 53–8. 22 indexed citations

17.

Garrido, Vanessa T., Venina Marcela Dominical, Fabı́ola Traina, et al.. (2012). Elevated plasma levels and platelet‐associated expression of the pro‐thrombotic and pro‐inflammatory protein, T NFSF14 (LIGHT), in sickle cell disease. British Journal of Haematology. 158(6). 788–797. 25 indexed citations

18.

Sugimoto, Yuka, Mikkael A. Sekeres, Hideki Makishima, et al.. (2012). Cytogenetic and molecular predictors of response in patients with myeloid malignancies without del[5q] treated with lenalidomide. Journal of Hematology & Oncology. 5(1). 4–4. 18 indexed citations

19.

Mali, Raghuveer Singh, Baskar Ramdas, Peilin Ma, et al.. (2011). Rho Kinase Regulates the Survival and Transformation of Cells Bearing Oncogenic Forms of KIT, FLT3, and BCR-ABL. Cancer Cell. 20(3). 357–369. 79 indexed citations

20.

Traina, Fabı́ola, et al.. (2007). Chronic Liver Abnormalities in Sickle Cell Disease: A Clinicopathological Study in 70 Living Patients. Acta Haematologica. 118(3). 129–135. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact